Hana Vlášková

739 citations

27 papers · 483 indexed · h-index 13

Co-authors: Lenka Dvořáková Helena Poupětová M. Elleder Martin Hřebı́ček Helena Hůlková Helena Jahnová Maria Kousi Sarenur Gökben
Topics: Lysosomal Storage Disorders Research (10 papers)Cardiomyopathy and Myosin Studies (6 papers)Metabolism and Genetic Disorders (5 papers)
Cited by: Physiology Clinical Biochemistry
Journals: Brain Gene Nutrients
Partner nations: Czechia United Kingdom Slovakia

In The Last Decade

Hana Vlášková

26 papers receiving 473 citations

Peers

Countries citing papers authored by Hana Vlášková

Since Specialization

Citations

This map shows the geographic impact of Hana Vlášková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hana Vlášková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hana Vlášková more than expected).

Fields of papers citing papers by Hana Vlášková

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hana Vlášková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hana Vlášková. The network helps show where Hana Vlášková may publish in the future.

Co-authorship network of co-authors of Hana Vlášková

This figure shows the co-authorship network connecting the top 25 collaborators of Hana Vlášková. A scholar is included among the top collaborators of Hana Vlášková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hana Vlášková. Hana Vlášková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of Newborn Screening and Early Dietary Management on Clinical Outcome of Patients with Long Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency and Medium Chain Acyl-CoA Dehydrogenase Deficiency—A Retrospective Nationwide Study 2021 ·Nutrients ·(unknown),Eva Hrubá,Markéta Pavlı́ková,(unknown),(unknown),Petr Chrastina,Hana Vlášková,Bohdan Kousal,Vratislav Smolka,(unknown),Tomáš Adam,David Friedecký,Pavel Ješina,J Zeman,Viktor Kožich,Tomáš Honzík	6
2	Transcript, protein, metabolite and cellular studies in skin fibroblasts demonstrate variable pathogenic impacts of NPC1 mutations 2020 ·Orphanet Journal of Rare Diseases ·(unknown),(unknown),Ladislav Kuchař,Ondřej Lukšan,Befekadu Asfaw,Hana Vlášková,(unknown),(unknown),Helena Poupětová,Helena Jahnová,Helena Hůlková,J. Ledvinová,Lenka Dvořáková,Jakub Sikora,M Jirsa,Marie T. Vanier,Martin Hřebı́ček	4
3	Amyotrophy, cerebellar impairment and psychiatric disease are the main symptoms in a cohort of 14 Czech patients with the late-onset form of Tay–Sachs disease 2019 ·Journal of Neurology ·Helena Jahnová,Helena Poupětová,(unknown),Hana Vlášková,(unknown),Radim Mazanec,Alena Zumrová,(unknown),Zuzana Mušová,Martin Magner	16
4	Late diagnosis of mucopolysaccharidosis type IVB and successful aortic valve replacement in a 60-year-old female patient 2018 ·Cardiovascular Pathology ·Gabriela Dostálová,(unknown),Jaroslav Lindner,Helena Hůlková,Helena Poupětová,Hana Vlášková,Jakub Sikora,Aleš Linhart,J Zeman,Martin Magner	4
5	Familiar Amyloid Polyneuropathy – a Case Report 2015 ·Česká a slovenská neurologie a neurochirurgie ·Tomáš Pika,(unknown),Helena Hůlková,Hana Vlášková,Pavel Otruba,(unknown),(unknown)	0
6	Insights into Severe 5,10-Methylenetetrahydrofolate Reductase Deficiency: Molecular Genetic and Enzymatic Characterization of 76 Patients 2015 ·Human Mutation ·Patricie Burda,Alexandra Schäfer,Terttu Suormala,(unknown),Céline Bürer,Dorothea M. Heuberger,Michele Frapolli,Cecilia Giunta,Jitka Sokolová,Hana Vlášková,Viktor Kožich,Hans Georg Koch,Brian Fowler,D. Sean Froese,Matthias R. Baumgartner	52
7	Observational, retrospective study of a large cohort of patients with Niemann-Pick disease type C in the Czech Republic: a surprisingly stable diagnostic rate spanning almost 40 years 2014 ·Orphanet Journal of Rare Diseases ·Helena Jahnová,Lenka Dvořáková,Hana Vlášková,Helena Hůlková,Helena Poupětová,Martin Hřebı́ček,Pavel Ješina	45
8	Hyperuricemia and gout due to deficiency of hypoxanthine–guanine phosphoribosyltransferase in female carriers: New insight to differential diagnosis 2014 ·Clinica Chimica Acta ·(unknown),Karel Pavelká,Hana Vlášková,Blanka Stibůrková	18
9	Systemic AL amyloidosis with unusual cutaneous presentation unmasked by carotenoderma 2013 ·Amyloid ·Helena Hůlková,(unknown),(unknown),(unknown),J. Hanuš,(unknown),Miroslav Souček,Ivana Márová,Josef Feit,Iva Staniczková Zambo,(unknown),Hana Vlášková,(unknown),Petr Novák,Zdeněk Kostrouch,M. Elleder	1
10	Clinical spectrum in CADASIL family with a new mutation 2013 ·Biomedical Papers ·Tomáš Peisker,(unknown),Martin Hřebı́ček,Hana Vlášková,(unknown),Aleš Bartoš	6
11	Prevalence of Fabry disease in male patients with unexplained left ventricular hypertrophy in primary cardiology practice: prospective Fabry cardiomyopathy screening study (FACSS) 2013 ·Journal of Inherited Metabolic Disease ·Tomáš Paleček,(unknown),Helena Poupětová,Hana Vlášková,Petr Kuchynka,(unknown),Sudheera Magage,Aleš Linhart	43
12	Mosaic tissue distribution of the tandem duplication of LAMP2 exons 4 and 5 demonstrates the limits of Danon disease cellular and molecular diagnostics 2013 ·Journal of Inherited Metabolic Disease ·(unknown),Ondřej Pelák,Tomáš Kalina,Hana Vlášková,Lenka Dvořáková,Tomáš Honzík,Tomáš Paleček,Petr Kuchynka,Martin Mašek,J Zeman,M. Elleder,Jakub Sikora	13
13	Danon disease: A focus on processing of the novel LAMP2 mutation and comments on the beneficial use of peripheral white blood cells in the diagnosis of LAMP2 deficiency 2012 ·Gene ·(unknown),Hana Vlášková,(unknown),Tomáš Kalina,Miloš Kubánek,(unknown),Lenka Dvořáková,M. Elleder,Jakub Sikora	22
14	Disruption of OTC promoter-enhancer interaction in a patient with symptoms of ornithine carbamoyltransferase deficiency 2010 ·Human Mutation ·Ondřej Lukšan,M Jirsa,(unknown),(unknown),(unknown),(unknown),(unknown),Hana Vlášková,Martin Hřebı́ček,Lenka Dvořáková	12
15	Treatment of cataplexy in Niemann–Pick disease type C with the use of miglustat 2010 ·European Journal of Paediatric Neurology ·Marcin Żarowski,Barbara Steinborn,(unknown),Lenka Dvořáková,Hana Vlášková,Sanjeev V. Kothare	15
16	Danon disease - a disorder of autophagy as a cause of hypertrophic cardiomyopathy 2010 ·Cor et Vasa ·Miloš Kubánek,M. Elleder,Jakub Sikora,Marek Šramko,Jana Malušková,Lenka Dvořáková,Hana Vlášková,Martin Kotrč,(unknown),Petr Ridzoň,(unknown),František Toušek,Ivan Málek,Jan Pirk	1
17	Mucopolysaccharidosis type I in 21 Czech and Slovak patients: Mutation analysis suggests a functional importance of C‐terminus of the IDUA protein 2009 ·American Journal of Medical Genetics Part A ·(unknown),Clare Beesley,Linda Berná,(unknown),(unknown),(unknown),Hana Vlášková,Helena Poupětová,J Zeman,Martin Magner,(unknown),Bryan Winchester,Martin Hřebı́ček,Lenka Dvořáková	29
18	Mutations in CLN7/MFSD8 are a common cause of variant late-infantile neuronal ceroid lipofuscinosis 2009 ·Brain ·Maria Kousi,Eija Siintola,Lenka Dvořáková,Hana Vlášková,Julie Turnbull,Meral Topçu,Deniz Yüksel,Sarenur Gökben,Berge A. Minassian,M. Elleder,Sara Mole,Anna-Elina Lehesjoki	94
19	Atypical CLN2 with later onset and prolonged course: a neuropathologic study showing different sensitivity of neuronal subpopulations to TPP1 deficiency 2008 ·Acta Neuropathologica ·M. Elleder,Lenka Dvořáková,(unknown),Hana Vlášková,Helena Hůlková,Rastislav Druga,Helena Poupětová,(unknown),(unknown)	29
20	A case of excessive autophagocytosis with multiorgan involvement and low clinical penetrance. 2007 ·PubMed ·Jakub Sikora,Lenka Dvořáková,Hana Vlášková,(unknown),(unknown),Jiří Špaček,M. Elleder	1

About Hana Vlášková

Hana Vlášková is a scholar working on Clinical Biochemistry, Physiology and Rheumatology, having authored 27 papers that have together received 483 indexed citations. Recurring topics across this work include Lysosomal Storage Disorders Research (10 papers), Cardiomyopathy and Myosin Studies (6 papers) and Metabolism and Genetic Disorders (5 papers). The work is most often cited by research in Physiology (272 citations), Clinical Biochemistry (58 citations) and Physiology (36 citations). Hana Vlášková has collaborated with scholars based in Czechia, United Kingdom and Slovakia. Frequent co-authors include Lenka Dvořáková, Helena Poupětová, M. Elleder, Martin Hřebı́ček, Helena Hůlková, Helena Jahnová, Maria Kousi, Sarenur Gökben, Berge A. Minassian and Deniz Yüksel. Their work appears in journals such as Brain, Gene and Nutrients.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact